Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Edgewise Therapeutics, Inc.(EWTX) | 5,350,000 | 5,350,000 | 0 | $168.53M | $217.37M | 12.62% | +$48.85M |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 94,946 | 94,946 | 0 | $125.41M | $188.89M | 10.97% | +$63.48M |
| Hemab Therapeutics Hldgs Inc | 0 | 4,180,550 | +4,180,550 | $0 | $153.55M | 8.92% | +$153.55M |
| Brookfield CorporationCL A(BN) | 3,496,245 | 3,496,245 | 0 | $141.49M | $149.53M | 8.68% | +$8.04M |
| MapLight Therapeutics, Inc.(MPLT) | 3,686,622 | 3,686,622 | 0 | $74.95M | $132.13M | 7.67% | +$57.18M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,325,000 | 1,125,000 | -200,000 | $122.40M | $131.70M | 7.65% | +$9.30M |
| Avalyn Pharmaceuticals Inc | 0 | 3,883,289 | +3,883,289 | $0 | $127.84M | 7.42% | +$127.84M |
| Salesforce, Inc.(CRM) | 393,187 | 393,187 | 0 | $73.40M | $61.60M | 3.58% | -$11.80M |
| ArriVent BioPharma, Inc.(AVBP) | 1,942,142 | 1,500,000 | -442,142 | $44.81M | $52.11M | 3.03% | +$7.30M |
| Enliven Therapeutics Inc | 1,280,000 | 1,000,000 | -280,000 | $50.18M | $50.75M | 2.95% | +$574.0K |
| Crinetics Pharmaceuticals In | 1,550,000 | 1,320,000 | -230,000 | $56.30M | $49.39M | 2.87% | -$6.90M |
| Pharvaris N V COM | 1,750,000 | 1,400,000 | -350,000 | $49.44M | $48.41M | 2.81% | -$1.03M |
| Floor & Decor Holdings, Inc.CL A(FND) | 0 | 797,000 | +797,000 | $0 | $47.31M | 2.75% | +$47.31M |
| Vaxcyte, Inc.(PCVX) | 860,000 | 800,000 | -60,000 | $49.97M | $46.50M | 2.70% | -$3.47M |
| 4d Molecular Therapeutics In | 3,650,737 | 3,249,178 | -401,559 | $33.99M | $43.21M | 2.51% | +$9.23M |
| Viridian Therapeutics, Inc.(VRDN) | 2,000,000 | 2,135,000 | +135,000 | $39.12M | $39.22M | 2.28% | +$100.0K |
| Celldex Therapeutics, Inc.(CLDX) | 1,200,000 | 1,025,000 | -175,000 | $38.06M | $38.14M | 2.21% | +$76.3K |
| Alumis Inc | 0 | 1,100,000 | +1,100,000 | $0 | $30.95M | 1.80% | +$30.95M |
| Xenon Pharmaceuticals Inc.(XENE) | 485,438 | 485,438 | 0 | $28.23M | $29.30M | 1.70% | +$1.07M |
| Alibaba Group Holding LimitedADS(BABA) | 257,327 | 257,327 | 0 | $32.28M | $24.70M | 1.43% | -$7.59M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 960,394 | +960,394 | $0 | $21.33M | 1.24% | +$21.33M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 2,185,923 | 2,250,000 | +64,077 | $19.56M | $17.14M | 1.00% | -$2.42M |
| Insmed Incorporated(INSM) | 0 | 120,723 | +120,723 | $0 | $12.87M | 0.75% | +$12.87M |
| Marqeta, Inc.CL A(MQ) | 441,558 | 441,558 | 0 | $1.80M | $7.17M | 0.42% | +$5.37M |
| LanzaTech Global, Inc.(LNZA) | 158,148 | 158,148 | 0 | $2.53M | $1.08M | 0.06% | -$1.45M |
| Apogee Therapeutics Inc | 450,000 | 0 | -450,000 | $37.88M | $0 | — | -$37.88M |
| BioMarin Pharmaceutical Inc.(BMRN) | 660,000 | 0 | -660,000 | $37.28M | $0 | — | -$37.28M |
| Valneva SEADS(VALN) | 1,057,421 | 0 | -1,057,421 | $6.61M | $0 | — | -$6.61M |